GoodRx Holdings, Inc. (GDRX) P/E Ratio History
UndervaluedTrading at 35.5x vs 5Y avg 927.3x · 22th percentile · Below historical baseline · Data 2020–2026
Loading P/E history...
P/E Ratio Analysis
As of July 8, 2026, GoodRx Holdings, Inc. (GDRX) trades at a price-to-earnings ratio of 35.5x, with a stock price of $3.03 and trailing twelve-month earnings per share of $0.09.
The current P/E is 96% below its 5-year average of 927.3x. Over the past five years, GDRX's P/E has ranged from a low of 23.1x to a high of 7722.2x, placing the current valuation at the 22th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.4x, GDRX trades at a 52% premium to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 198.8x.
Relative to the broader market, GDRX commands a significant premium over the S&P 500 median P/E of 25.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GDRX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GDRX Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
GDRX P/E vs Peers
Patient Engagement, Intake and Payments peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $8B | 70.9 | - | -4% | |
| $118M | 23.3 | - | +125%Best | |
| $4B | 23.2 | 0.44Best | -12% | |
| $2B | 47.4 | 7.07 | +14% | |
| $133B | 75.1 | - | -62% | |
| $97B | 21.0Lowest | - | +49% | |
| $56B | 37.2 | - | +87% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
GDRX Historical P/E Data (2020–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $1.96 | $0.08 | 23.1x | -98% |
| FY2025 Q4 | Dec 31 2025 | $2.71 | $0.09 | 31.8x | -97% |
| FY2025 Q3 | - | $4.23 | $0.09 | 47.4x | -95% |
| FY2025 Q2 | Jun 30 2025 | $4.98 | $0.12 | 42.3x | -95% |
| FY2025 Q1 | Mar 31 2025 | $4.41 | $0.10 | 43.4x | -95% |
| FY2024 Q4 | - | $4.65 | $0.07 | 67.4x | -93% |
| FY2023 Q3 | Sep 30 2023 | $5.63 | $0.03 | 165.1x | -82% |
| FY2023 Q2 | Jun 30 2023 | $5.52 | $0.03 | 202.9x | -78% |
| FY2020 Q3 | Sep 30 2020 | $55.60 | $0.01 | 7722.2x | +733% |
Average P/E for displayed period: 927.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GDRX — Frequently Asked Questions
Quick answers to the most common questions about buying GDRX stock.
What is GDRX's P/E ratio?
GoodRx Holdings, Inc. (GDRX) trailing twelve-month P/E ratio is 35.5x, based on TTM diluted EPS of $0.09. The 5-year average P/E is 927.3x and the historical range spans 23.1x to 7722.2x.
Is GDRX stock overvalued or undervalued?
GDRX trades at 35.5x P/E, below its 5-year average of 927.3x. At the 22th percentile of its historical range (23.1x–7722.2x), the stock is priced at a discount to its own history.
Is GDRX stock expensive?
No, GDRX is not expensive on a historical basis. The current P/E of 35.5x is below the 5-year average of 927.3x and sits at the 22th percentile of its valuation range.
What is GDRX's historical P/E range?
Over the past 5 years, GDRX's P/E ratio has ranged from 23.1x to 7722.2x, with a median of 47.4x and an average of 927.3x. The current P/E of 35.5x places the stock at the 22th percentile of this range. Full historical data spans 2020–2026.
How does GDRX's P/E compare to the S&P 500?
GDRX trades at 35.5x P/E versus the S&P 500 median of 25.9x. The 37% premium to the market typically reflects higher expected earnings growth or quality.
How does GDRX's valuation compare to Healthcare peers?
GoodRx Holdings, Inc. P/E of 35.5x compares to the Healthcare sector median of 23.4x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is GDRX's PEG ratio?
GDRX PEG ratio is N/A, based on a P/E of 35.5x and EPS growth of 104.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is GDRX's earnings yield?
GDRX earnings yield is 2.82%, the inverse of its 35.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.